Covid-19 Vaccine Development Tools Market Outlook (2022-2032)
[250 Pages Report] Newly-released Covid-19 Vaccine Development Tools industry analysis report by Future Market Insights shows that global sales of Covid-19 Vaccine Development Tools in 2021 was held at US$ 17.2 Bn. With 10.7%, theprojectedmarketgrowthduring2022 - 2032 is expected to be significantly higher than the historical growth. Laboratory Technologies are expected to be the highest revenue generating type, accounting for an absolute dollar opportunity of nearly US$ 32.8 Bn during 2022 – 2032.
Attributes
Details
Covid-19 Vaccine Development Tools Market CAGR (2022 to 2032)
10.7%
Covid-19 Vaccine Development Tools Market Size (2022)
US$ 18.9 Billion
Covid-19 Vaccine Development Tools Market Size (2032)
US$ 51.6 Billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue of Covid-19 Vaccine Development Tools from 2020 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Covid-19 Vaccine Development Tools industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2020 to 2021, market value of the Covid-19 Vaccine Development Tools industry increased at around 9% CAGR, wherein, countries such as the U.S., UK, China, South Korea and Japan held significant share in the global market.
Owing to this, Covid-19 Vaccine Development Tools market is projected to grow at a CAGR of 10.7% over the coming 10 years.
The Covid-19 Vaccine Development Tools market reached a valuation of US$ 18.9 Bn in 2021 increased by 6% over the last year. Future Market Insights estimates that Covid-19 Vaccine Development Tools revenue will grow 2.7X from 2022 to 2032, reaching nearly US$ 51.6 Bn in 2032.
Laboratory Technology segment among technologies, is expected to grow at the highest rate of 10.7% CAGR.
Going by the country, US is expected to produce largest revenue of $12.8 Bn by 2032.
The market in APAC is projected to register highest growth of 10.7% in the coming ten years.
What Factors are leading Towards Growth of Covid-19 Vaccine Development Tools Market?
The industry is expected to maintain its growth in the following years, owing to a large influx of vaccine designers and manufacturers from around the world. Despite the rapid development and deployment of vaccines, the SARS-CoV-2 infection curve has only recently begun to level off, particularly in developed countries.
Several factors are contributing to the development of this market, including artificial intelligence's critical role in the COVID-19 vaccine race, an expanding pool of collaborations to expedite vaccine research and clinical trials, and rigorous funding initiatives by government and private entities. The current environment of expedited vaccine research and clinical trials has motivated collaboration among vaccine developers and industry players.
SARS-COV-2 variants began to appear in the vaccine market in 2020, necessitating recertification of the effectiveness of the first-generation vaccines that were designed for use in that development period.
Pharmaceutical firms are focusing on creating long-term solutions for the SARSCOPE-C disease, which is prompting manufactures such as Thermo Fisher Scientific Inc., Hamilton Company, Sartorius AG, Agilent Technologies, and Bio-Rad Laboratories Inc. to expand their tool portfolio that is used only in the development of the vaccine for COVID-19.
AI has enormous potential to facilitate and revolutionise the discovery of innovative COVID-19 vaccines. AI is expected to play an important role in the development of vaccines for emerging coronavirus variants, and entities operating in this market space are collaborating with vaccine developers to further expand the market. Nanotronics, for example, announced in April 2021 that it has partnered with various key COVID-19 vaccine developers to assist in the efficient management of data linked with COVID-19 vaccine development activities through the use of AI-based online tools.
Find your sweet spots for generating winning opportunities in this market.
Which Region is projected to Offer the Largest Opportunity for Covid-19 Vaccine Development Tools?
Asia Pacific region is expected to register the highest CAGR during the forecast period due to increased demand for Covid-19 Vaccine Development Tools in developing countries, especially India and China. This can be attributed to its high Covid-affected population.
The International Conference on Genomes, Synaptic RNAs, and Vaccines 2019 hosted more than 420 researchers affiliated with ten international and Chinese institutions, who explored cutting-edge genome sequencing, cells, interactions, and immune response methods. The use of advanced sequencing techniques in China enabled the identification of the COVID-19 genome sequence and allowed the speedy implementation of vaccines against SARS-CoV-2.Chinese researchers used next-generation sequencing, electron microscopy, flow cytometry, and other methods to conduct studies on the SARS-CoV-2 genome, viral structural analysis, and cell imaging.
Country-wise Analysis
Which Country Lies at the Centre-stage for Covid-19 Vaccine Development Tools Revenue?
U.S. accounts for nearly 28% of the global Covid-19 vaccine development tools market revenue. The growth in country’s market can be attributed to a variety of factors, including increased R&D activities, funding initiatives, presence of key players, rising COVID-19 cases, and a high population base receiving COVID-19 vaccine, among others. Furthermore, government initiatives promoting the development of a COVID-19 vaccine can be attributed to market growth. For example, the United States government launched Operation Warp Speed, a public-private collaboration for the development, production, and distribution of COVID-19 vaccines.
Monitoring the rate of mutation is critical for the development of an effective vaccine against SARS-CoV-2. Companies in the United States are developing surveillance infrastructure to track SARS-CoV-2 mutations. Illumina, Inc. and Helix announced their collaboration to build a national surveillance infrastructure in the United States to monitor potential emergence and prevalence of novel SARS-CoV-2 strains in January 2021. Illumina's sequencing technology will be combined with Helix's nationwide testing footprint to expand security efforts established by the federal government for the early detection and evaluation of SARS-CoV-2 variants.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which Country Lies at the Centre-stage for Covid-19 Vaccine Development Tools Revenue?
U.S. accounts for nearly 28% of the global Covid-19 vaccine development tools market revenue. The growth in country’s market can be attributed to a variety of factors, including increased R&D activities, funding initiatives, presence of key players, rising COVID-19 cases, and a high population base receiving COVID-19 vaccine, among others. Furthermore, government initiatives promoting the development of a COVID-19 vaccine can be attributed to market growth. For example, the United States government launched Operation Warp Speed, a public-private collaboration for the development, production, and distribution of COVID-19 vaccines.
Monitoring the rate of mutation is critical for the development of an effective vaccine against SARS-CoV-2. Companies in the United States are developing surveillance infrastructure to track SARS-CoV-2 mutations. Illumina, Inc. and Helix announced their collaboration to build a national surveillance infrastructure in the United States to monitor potential emergence and prevalence of novel SARS-CoV-2 strains in January 2021. Illumina's sequencing technology will be combined with Helix's nationwide testing footprint to expand security efforts established by the federal government for the early detection and evaluation of SARS-CoV-2 variants.
Category-wise Insights
Why Laboratories Technology Stands as the Revenue Base for Covid-19 Vaccine Development?
The laboratory technologies segment dominates the market, accounting for over 95% of total revenue. The use of laboratory technologies to grow the potency of vaccines, including polymerase chain reaction, cell culture, hemagglutination, flow cytometry, and spectrometry, is anticipated to favor the growth and delivery of vaccine diagnostic segments over the next five years. PCR and qPCR will constitute the most noteworthy revenue of the laboratory technologies industry in 2020. The broad use of PCR technologies in vaccine surveillance and efficacy testing has led to the industry's rapid expansion.
Medical professionals are also working to bring technologies like vaccine trackers and optimize management systems online. These tools are largely being employed by established companies to conduct research and development activities. Between mid-November 2020 and the present, Vaccine Predictor, a website, has been available online. This tool enables users to evaluate the CDC's recently updated vaccine portfolio and generate development timelines, according to Research and development activities.
Why Vaccine Research Segment Dominates Revenue among Applications?
The vaccine research segment dominated the market, accounting for around 44% of revenue. Several factors, including increased government funding, extensive research by universities and healthcare organisations, and increased business development strategies by prominent pharmaceutical companies, are driving the segment's growth. Furthermore, the segment's growth can be attributed to ongoing research activities aimed at improving the vaccine planning process.
For example, Stanford University researchers are working on developing a single-dose coronavirus vaccine that could potentially be stored at room temperature in January 2021. This could potentially help to reduce the cost of vaccine storage and transportation. Furthermore, for COVID-19 target discoveries, companies are increasingly engaging in business growth strategies such as agreements, alliances, and collaborations.
A new webtool based on the COVID-19 Vaccine Predictor was released in November 2020. This webtool allows users to explore an updated vaccine portfolio and evaluate the timeline for Research and development activities. Scientists collaborated to determine diagnosing and treating infectious diseases during this study to discover useful biomarkers to monitor at-risk individuals. These valuable insights helped to lead to a vaccine against COVID-19.
Competitive Analysis
The key players in Covid-19 vaccine development tools market include Thermo Fisher Scientific, Inc., Celerion, Cole-Parmer Instrument Company, LLC, Pfizer Inc., Sartorius AG, STEMCELL Technologies Inc., AB Sciex Pte. Ltd., Illumina, Inc., Agilent Technologies, and Bio-Rad Laboratories, Inc., among others.
Some of the recent developments of key Covid-19 Vaccine Development Tools providers are as follows:
In April 2021, Nanotronics announced that it has partnered with various key COVID-19 vaccine developers to assist in the efficient management of data linked with COVID-19 vaccine development activities through the use of AI-based online tools.
In February 2021, Pharmaceuticals business BioNTech extended its partnership with Merck KGaA to create a delay for the development of tools and technologies required for the production of mRNA-based vaccines for COVID-19. The strategic choice to extend the collaboration agreement with Merck is intended to increase the speed of mRNA-based vaccine production.
In January 2021, Illumina, Inc. and Helix joined forces to build a national surveillance infrastructure to monitor the onset and prevalence of novel SARS-CoV-2 strains in various parts of the U.S.
In October 2020, Sartorius AG will expand its presence in North America by opening a 40,000-square-foot Customer Engagement Center. The new Marlborough location will provide optimised factory user acceptance test and will be outfitted with new bioprocess equipment.
Similarly, recent developments related to companies offering Covid-19 Vaccine Development Tools have been tracked by the team at Future Market Insights, which are available in the full report.
Covid-19 Vaccine Development Tools Market Report Scope
Attribute
Details
Forecast Period
2022 to 2032
Historical Data Available for
2020 to 2021
Market Analysis
US$ Bn for Value
Key Regions Covered
North America, Latin America, Europe, Asia-Pacific, and MEA
Market Segments Covered in Covid-19 Vaccine Development Tools Industry Analysis
By Technology:
Laboratory Technologies
Next Generation Sequencing
PCR & qPCR
Flow Cytometry
Spectrometry
Microscopy & Electron Microscopy
Preparative & Process Chromatography
Nucleic Acid Isolation & Purification
Transfection Electroporation
Cell Culture
Automated Liquid Handling
Online Technologies
Interactive Web Technologies
Vaccine Management & Tracker Technologies
By Application:
Vaccine Research
Vaccine Process Development
Vaccine Quality Assurance/Quality Control
By End-use:
Pharma & Biopharma Companies
Contract Research Organization (CROs)
Academic & Research Institutes
Frequently Asked Questions
How much is the current worth of the Covid-19 Vaccine Development Tools market?
The global Covid-19 Vaccine Development Tools market is worth more than US$ 17.2 Bn at present.
What is the sales forecast for Covid-19 Vaccine Development Tools?
Value of Covid-19 Vaccine Development Tools are projected to increase at a CAGR of around 10.7% during 2022 – 2032.
What was the last 5 year’s market CAGR?
Value of Covid-19 Vaccine Development Tools increased at a CAGR of around 8.9% during 2020 – 2021.
What is driving revenue for Covid-19 Vaccine Development Tools?
The growing competition amongst the vaccine developers is one of the prominent market drivers for Covid-19 vaccine development tools market.
What are the top five players of Covid-19 Vaccine Development Tools market?
Top five players of Covid-19 Vaccine Development Tools market include Thermo Fisher Scientific Inc., Celerion, Cole-Parmer Instrument Company Llc., Pfizer, Sartorius AG
Which are the top 5 countries driving demand for Covid-19 Vaccine Development Tools?
Top 5 countries driving demand for Covid-19 Vaccine Development Tools are U.S., U.K., China, Japan, South Korea
What is the outlook for the market in Asia-Pacific?
Asia Pacific accounted for around 40% of global Covid-19 Vaccine Development Tools demand in 2021.
At what percentage is sales of Covid-19 Vaccine Development Tools going to register growth in Europe?
The European market for Covid-19 Vaccine Development Tools is projected to expand at a CAGR of around 10% during 2022 – 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Covid-19 Vaccine Development Tools
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Covid-19 Vaccine Development Tools Market, by Key Countries
4.2. Covid-19 Vaccine Development Tools Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Covid-19 Vaccine Development Tools Market Demand Analysis 2020-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2020-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Covid-19 Vaccine Development Tools Market Value Analysis 2020-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2020-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Technology, 2020-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032
8.3.1. Laboratory Technologies
8.3.1.1. Next Generation Sequencing
8.3.1.2. PCR & qPCR
8.3.1.3. Flow Cytometry
8.3.1.4. Spectrometry
8.3.1.5. Microscopy & Electron Microscopy
8.3.1.6. Preparative & Process Chromatography
8.3.1.7. Nucleic Acid Isolation & Purification
8.3.1.8. Transfection Electroporation
8.3.1.9. Cell Culture
8.3.1.10. Automated Liquid Handling
8.3.2. Online Technologies
8.3.2.1. Interactive Web Technologies
8.3.2.2. Vaccine Management & Tracker Technologies
8.4. Market Attractiveness Analysis By Technology
9. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2020-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
9.3.1. Vaccine Research
9.3.2. Vaccine Process Development
9.3.3. Vaccine Quality Assurance/Quality Control
9.4. Market Attractiveness Analysis By Application
10. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By End-Use
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End-Use, 2020-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-Use, 2022-2032
10.3.1. Pharma & Biopharma Companies
10.3.2. Contract Research Organization (CROs)
10.3.3. Academic & Research Institutes
10.4. Market Attractiveness Analysis By End-Use
11. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2020-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Technology
12.4.3. By End-Use
12.4.4. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Technology
12.5.3. By End-Use
12.5.4. By Application
13. Latin America Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Technology
13.4.3. By End-Use
13.4.4. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Technology
13.5.3. By End-Use
13.5.4. By Application
14. Europe Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Technology
14.4.3. By End-Use
14.4.4. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Technology
14.5.3. By End-Use
14.5.4. By Application
15. Asia Pacific Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Technology
15.4.3. By End-Use
15.4.4. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Technology
15.5.3. By End-Use
15.5.4. By Application
16. Middle East and Africa Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Technology
16.4.3. By End-Use
16.4.4. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Technology
16.5.3. By End-Use
16.5.4. By Application
17. Key Countries Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Covid-19 Vaccine Development Tools Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.2.2.1. By Technology
17.2.2.2. By End-Use
17.2.2.3. By Application
17.3. Canada Covid-19 Vaccine Development Tools Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.3.2.1. By Technology
17.3.2.2. By End-Use
17.3.2.3. By Application
17.4. Mexico Covid-19 Vaccine Development Tools Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.4.2.1. By Technology
17.4.2.2. By End-Use
17.4.2.3. By Application
17.5. Brazil Covid-19 Vaccine Development Tools Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.5.2.1. By Technology
17.5.2.2. By End-Use
17.5.2.3. By Application
17.6. Germany Covid-19 Vaccine Development Tools Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.6.2.1. By Technology
17.6.2.2. By End-Use
17.6.2.3. By Application
17.7. France Covid-19 Vaccine Development Tools Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.7.2.1. By Technology
17.7.2.2. By End-Use
17.7.2.3. By Application
17.8. Italy Covid-19 Vaccine Development Tools Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.8.2.1. By Technology
17.8.2.2. By End-Use
17.8.2.3. By Application
17.9. BENELUX Covid-19 Vaccine Development Tools Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.9.2.1. By Technology
17.9.2.2. By End-Use
17.9.2.3. By Application
17.10. UK Covid-19 Vaccine Development Tools Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.10.2.1. By Technology
17.10.2.2. By End-Use
17.10.2.3. By Application
17.11. Nordic Countries Covid-19 Vaccine Development Tools Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.11.2.1. By Technology
17.11.2.2. By End-Use
17.11.2.3. By Application
17.12. China Covid-19 Vaccine Development Tools Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.12.2.1. By Technology
17.12.2.2. By End-Use
17.12.2.3. By Application
17.13. Japan Covid-19 Vaccine Development Tools Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.13.2.1. By Technology
17.13.2.2. By End-Use
17.13.2.3. By Application
17.14. South Korea Covid-19 Vaccine Development Tools Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.14.2.1. By Technology
17.14.2.2. By End-Use
17.14.2.3. By Application
17.15. GCC Countries Covid-19 Vaccine Development Tools Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.15.2.1. By Technology
17.15.2.2. By End-Use
17.15.2.3. By Application
17.16. South Africa Covid-19 Vaccine Development Tools Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.16.2.1. By Technology
17.16.2.2. By End-Use
17.16.2.3. By Application
17.17. Turkey Covid-19 Vaccine Development Tools Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032
17.17.2.1. By Technology
17.17.2.2. By End-Use
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Thermo Fisher Scientific, Inc
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Celerion
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Cole-Parmer Instrument Company, Llc.
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Pfizer
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Sartorius AG
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Stemcell Technologies Inc.
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. AB Sciex Pte. Ltd.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Illumina, Inc.
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. Eurofins Scientific
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. Agilent Technologies
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
19.3.11. Bio-Rad Laboratories, Inc.
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Sales Footprint
19.3.11.4. Strategy Overview
19.3.12. Danaher
19.3.12.1. Overview
19.3.12.2. Product Portfolio
19.3.12.3. Sales Footprint
19.3.12.4. Strategy Overview
19.3.13. Merck KGaA
19.3.13.1. Overview
19.3.13.2. Product Portfolio
19.3.13.3. Sales Footprint
19.3.13.4. Strategy Overview
19.3.14. Qiagen N.V.
19.3.14.1. Overview
19.3.14.2. Product Portfolio
19.3.14.3. Sales Footprint
19.3.14.4. Strategy Overview
19.3.15. Shimadzu Corporation
19.3.15.1. Overview
19.3.15.2. Product Portfolio
19.3.15.3. Sales Footprint
19.3.15.4. Strategy Overview
20. Assumptions and Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021
Table 2: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032
Table 3: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021
Table 4: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032
Table 5: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021
Table 6: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032
Table 7: Global Covid-19 Vaccine Development Tools Market, By Region, 2020 – 2021
Table 8: Global Covid-19 Vaccine Development Tools Market, By Region, 2022 – 2032
Table 9: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021
Table 10: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032
Table 11: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021
Table 12: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032
Table 13: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021
Table 14: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032
Table 15: North America Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021
Table 16: North America Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032
Table 17: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021
Table 18: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032
Table 19: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021
Table 20: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032
Table 21: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021
Table 22: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032
Table 23: Latin America Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021
Table 24: Latin America Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032
Table 25: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021
Table 26: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032
Table 27: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021
Table 28: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032
Table 29: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021
Table 30: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032
Table 31: Europe Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021
Table 32: Europe Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032
Table 33: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021
Table 34: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032
Table 35: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021
Table 36: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032
Table 37: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021
Table 38: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032
Table 39: Asia Pacific Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021
Table 40: Asia Pacific Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032
Table 41: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021
Table 42: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032
Table 43: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021
Table 44: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032
Table 45: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021
Table 46: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032
Table 47: MEA Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021
Table 48: MEA Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032
Table 49: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021
Table 50: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032
Table 51: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021
Table 52: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021
Table 54: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032
Table 55: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 – 2021
Table 56: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021
Table 58: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032
Table 59: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021
Table 60: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021
Table 62: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032
Table 63: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021
Table 64: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 65: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021
Table 66: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032
Table 67: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021
Table 68: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021
Table 70: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032
Table 71: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021
Table 72: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032
Figure 2: Global Covid-19 Vaccine Development Tools Market Absolute $ Historical Gain (2020 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032
Figure 4: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 5: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032
Figure 6: Global Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032
Figure 7: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032
Figure 8: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032
Figure 9: Global Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032
Figure 10: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 11: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032
Figure 12: Global Covid-19 Vaccine Development Tools Market Share, By Region, 2022 & 2032
Figure 13: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 14: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By Region – 2022-2032
Figure 15: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032
Figure 16: North America Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 17: North America Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032
Figure 18: North America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 19: North America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032
Figure 20: North America Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032
Figure 21: North America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032
Figure 22: North America Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032
Figure 23: North America Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032
Figure 24: North America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 25: North America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032
Figure 26: North America Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 28: North America Market Attractiveness Index, By Country – 2022-2032
Figure 29: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032
Figure 30: Latin America Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 31: Latin America Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032
Figure 32: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 33: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032
Figure 34: Latin America Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032
Figure 35: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032
Figure 36: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032
Figure 37: Latin America Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032
Figure 38: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 39: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032
Figure 40: Latin America Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032
Figure 41: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 42: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032
Figure 43: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032
Figure 44: Europe Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 45: Europe Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032
Figure 46: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 47: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032
Figure 48: Europe Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032
Figure 49: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032
Figure 50: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032
Figure 51: Europe Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032
Figure 52: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 53: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032
Figure 54: Europe Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032
Figure 55: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 56: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032
Figure 57: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032
Figure 58: MEA Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 59: MEA Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032
Figure 60: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 61: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032
Figure 62: MEA Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032
Figure 63: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032
Figure 64: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032
Figure 65: MEA Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032
Figure 66: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 67: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032
Figure 68: MEA Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032
Figure 69: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 70: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032
Figure 71: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032
Figure 72: Asia Pacific Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 73: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032
Figure 74: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 75: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032
Figure 76: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032
Figure 77: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032
Figure 78: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032
Figure 79: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032
Figure 80: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 81: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032
Figure 82: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032
Figure 83: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 84: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032
Figure 85: US Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: US Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 87: US Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 88: US Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 89: Canada Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 90: Canada Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 91: Canada Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 92: Canada Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 93: Brazil Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 94: Brazil Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 95: Brazil Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 96: Brazil Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 97: Mexico Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: Mexico Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 99: Mexico Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 100: Mexico Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 101: Germany Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 102: Germany Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 103: Germany Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 104: Germany Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 105: U.K. Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 106: U.K. Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 107: U.K. Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 108: U.K. Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 109: France Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: France Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 111: France Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 112: France Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 113: Italy Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 114: Italy Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 115: Italy Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 116: Italy Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 117: BENELUX Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 118: BENELUX Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 119: BENELUX Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 120: BENELUX Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 121: Nordic Countries Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 122: Nordic Countries Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 123: Nordic Countries Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 124: Nordic Countries Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 125: China Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 126: China Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 127: China Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 128: China Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 129: Japan Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 130: Japan Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 131: Japan Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 132: Japan Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 133: South Korea Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 134: South Korea Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 135: South Korea Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 136: South Korea Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 137: GCC Countries Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 138: GCC Countries Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 139: GCC Countries Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 140: GCC Countries Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 141: South Africa Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 142: South Africa Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 143: South Africa Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 144: South Africa Covid-19 Vaccine Development Tools Market Share, By Application, 2021
Figure 145: Turkey Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 146: Turkey Covid-19 Vaccine Development Tools Market Share, By Technology, 2021
Figure 147: Turkey Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021
Figure 148: Turkey Covid-19 Vaccine Development Tools Market Share, By Application, 2021
